“…Group B streptococcus, S. pneumoniae, and S. suis invade brain microvascular endothelial cells via transcellular mechanisms; however, the associated production of proinflammatory cytokines, the activity of pore-forming toxins, and the induction of plasmin activity may also lead to a concurrent weakening of the BBB, potentially opening a paracellular route of entry. In vivo and in vitro studies have shown that group B streptococci, pneumococci, and S. suis induce the production of a range of cytokines and chemokines, including IL-1, IL-6, IL-8, IL-10, TNF-␣, macrophage chemoattractant protein 1 (MCP-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), Gro-␣, and Gro-, in brain microvascular endothelial cells (109,(256)(257)(258)) and brain tissue (94,259,260). The stimulation of HBMECs with cytokines (including TNF-␣, IL-1, IL-6, and IL-17F) leads to cytoskeletal rearrangements and a redistribution of tight junction and adherens junction proteins, resulting in a decrease in barrier integrity (261)(262)(263)(264)(265)(266)(267).…”